{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:20:29Z","timestamp":1780316429691,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jacl.2019.09.007","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T12:09:40Z","timestamp":1569413380000},"page":"880-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Coronary artery disease in a child with homozygous familial hypercholesterolemia: Regression after liver transplantation"],"prefix":"10.1016","volume":"13","author":[{"given":"Constance E.","family":"Cephus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athar M.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Kristen","family":"Sexson Tejtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Moodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2019.09.007_bib1","first-page":"154908","article-title":"Homozygous familial hypercholesterolemia: case series and review of the literature","volume":"2011","author":"Palacio","year":"2011","journal-title":"Case Rep Transplant"},{"issue":"6","key":"10.1016\/j.jacl.2019.09.007_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/chd.12301","article-title":"Liver transplantation for HoFH in children: single center experience","volume":"10","author":"Cephus","year":"2015","journal-title":"Congenit Heart Dis"},{"issue":"5","key":"10.1016\/j.jacl.2019.09.007_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3476(82)80579-9","article-title":"Familial hypercholesterolemia: report of coronary death at age 3 in a homozygous child and prenatal diagnosis in a heterozygous sibling","volume":"100","author":"Rose","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.jacl.2019.09.007_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1399-0012.2007.00764.x","article-title":"Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation","volume":"22","author":"Schmidt","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacl.2019.09.007_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11883-014-0482-5","article-title":"Familial hypercholesterolemia \u2013 epidemiology, diagnosis and screening","volume":"17","author":"Singh","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2019.09.007_bib6","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.amjcard.2008.07.035","article-title":"Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia","volume":"102","author":"Kolansky","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2019.09.007_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.amjcard.2016.05.042","article-title":"Effects of liver transplantation on lipids and cardiovascular disease in children with homozygous familial hypercholesterolemia","volume":"118","author":"Martinez","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2019.09.007_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0021-9150(99)00109-4","article-title":"Familial hypercholesterolemia. Acceptor splice site (G -> C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-RHonduras-1 [LDL-R1061( -1) G -> C]","volume":"146","author":"Yu","year":"1999","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacl.2019.09.007_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40119-015-0037-z","article-title":"Familial hypercholesterolemia: a review of the natural history, diagnosis and management","volume":"4","author":"Najam","year":"2015","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.jacl.2019.09.007_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2014.09.058","article-title":"Seven-year clinical follow-up of a Chinese homozygous familial hypercholesterolemia child with premature xanthomas and coronary artery disease \u2013 A need for early diagnosis and aggressive treatment","volume":"177","author":"Jiang","year":"2014","journal-title":"Int J Cardiol"},{"issue":"32","key":"10.1016\/j.jacl.2019.09.007_bib12","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2019.09.007_bib13","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jacl.2019.09.007_bib14","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jacc.2017.06.058","article-title":"Efficacy of rosuvastatin in children with homozygous familial hypercholesterolemia and association with underlying genetic mutations","volume":"70","author":"Stein","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2019.09.007_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2016.02.009","article-title":"Homozygous familial hypercholesterolemia in childhood: genotype-phenotype description, established therapies and perspectives","volume":"247","author":"Sanna","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2019.09.007_bib16","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.113.001292","article-title":"Lomitapide and Mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia","volume":"129","author":"Rader","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2019.09.007_bib17","series-title":"Handbook of Pharmacogenomics and Stratified Medicine","first-page":"715","article-title":"Chaper 31:\u201cGenomics and Pharmacogenomics of Lipid-Lowering Therapies\u201d","author":"Docherty","year":"2014"},{"key":"10.1016\/j.jacl.2019.09.007_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S2213-8587(17)30044-X","article-title":"Long-term treatment with evolocumab assed to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesteroleamia: an interim subset analysis of the open-label TAUSSIG study","volume":"5","author":"Raal","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2019.09.007_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomized, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2019.09.007_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jacl.2018.05.007","article-title":"Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: rational and design of the HAUSER-RCT study","volume":"12","author":"Gaudet","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2019.09.007_bib21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/eurheartj\/eht015","article-title":"Diagnosis and treatment of familial hypercholesterolemia","volume":"34","author":"Hovingh","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2019.09.007_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacl.2015.05.001","article-title":"Treating homozygous familial hypercholesterolemia in a real-world setting: experiences with lomitapide","volume":"9","author":"Roeters van Lennep","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2019.09.007_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacl.2019.03.001","article-title":"Case report: the efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child","volume":"13","author":"Chacra","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2019.09.007_bib24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomized, double-blind, placebo-controlled trial","volume":"375","author":"Raal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2019.09.007_bib25","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.jacc.2013.07.081","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk","volume":"62","author":"Thomas","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacl.2019.09.007_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40265-019-01114-z","article-title":"Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials","volume":"79","author":"Fogacci","year":"2019","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jacl.2019.09.007_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/14656566.2018.1550071","article-title":"Mipomersen and its use in familial hypercholesterolemia","volume":"20","author":"Parham","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jacl.2019.09.007_bib28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.atherosclerosis.2007.08.017","article-title":"Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiography","volume":"197","author":"Santos","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2019.09.007_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2019.04.219","article-title":"Coronary computed tomography angiography and echocardiography in children with homozygous familial hypercholesterolemia","volume":"285","author":"Luirink","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2019.09.007_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jacl.2018.10.011","article-title":"Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: a systematic review","volume":"13","author":"Luirink","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2019.09.007_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jacl.2015.12.009","article-title":"Quality of life in patients treated with lipoprotein apheresis","volume":"10","author":"Rosada","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2019.09.007_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacl.2019.02.001","article-title":"Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: results of a nationwide survey (A-HIT1 registry)","volume":"13","author":"Kayikcioglu","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2019.09.007_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/lt.24696","article-title":"Health-related quality of life after pediatric liver transplantation: a systematic review","volume":"23","author":"Parmar","year":"2017","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jacl.2019.09.007_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1477-7525-8-150","article-title":"NgV. Experiences and barriers to health-related quality of life following liver transplantation: a qualitative analysis of the perspectives of pediatric patients and their parents","volume":"8","author":"Nicholas","year":"2010","journal-title":"Health Qual Life Outcomes"},{"issue":"36","key":"10.1016\/j.jacl.2019.09.007_bib35","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2019.09.007_bib36","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1056\/NEJM198412273112603","article-title":"Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia","volume":"311","author":"Bilheimer","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2019.09.007_bib37","first-page":"E25","article-title":"Preemptive liver transplantation in a child with familial hypercholesterolemia","volume":"15","author":"Maiorana","year":"2010","journal-title":"Pediatr Transplant"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741930279X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741930279X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:35:47Z","timestamp":1761831347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328741930279X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S193328741930279X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2019.09.007","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary artery disease in a child with homozygous familial hypercholesterolemia: Regression after liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2019.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}